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ABSTRACT
Clinical research is the foundation for advancing the
practice of medicine. However, the lack of seamless
integration between clinical research and patient care
workflow impedes recruitment efficiency, escalates
research costs, and hence threatens the entire clinical
research enterprise. Increased use of electronic health
records (EHRs) holds promise for facilitating this
integration but must surmount regulatory obstacles.
Among the unintended consequences of current
research oversight are barriers to accessing patient
information for prescreening and recruitment,
coordinating scheduling of clinical and research visits,
and reconciling information about clinical and research
drugs. We conclude that the EHR alone cannot overcome
barriers in conducting clinical trials and comparative
effectiveness research. Patient privacy and human
subject protection policies should be clarified at the local
level to exploit optimally the full potential of EHRs, while
continuing to ensure participant safety. Increased
alignment of policies that regulate the clinical and
research use of EHRs could help fulfill the vision of more
efficiently obtaining clinical research evidence to improve
human health.
Clinical research, including clinical trials and
comparative effectiveness research,1 provides the
foundation for improving medical treatment.
However, recruitment efforts and research work-
flow inefficiency are driving up the costs of research
and hence threatening the clinical research enter-
prise.2 Clinical research requires collaboration
between clinicians and researchers, but such
collaborations are poorly supported. A fundamental
problem is the lack of alignment between clinical
research and patient care workflows. Efforts to
recruit patients into studies often interrupt clinical
workflow and place heavy burdens on time-pres-
sured clinicians and administrators.3 Another major
barrier to participation in clinical research for
clinicians is that the time commitment to accom-
modate research generally goes unrewarded.
Research activities can also create conflict at prac-
tice-based clinical research sites over limited
resources (eg, staff, exam rooms, and equipment),
discouraging many clinical sites from participating
in research. The lack of coordination between
research and clinical workflows often results in
redundant visits and tests for patients, discouraging
their participation as well.4
With the goal of transforming the US clinical
research enterprise, the Institute of Medicine has
called for a ‘learning healthcare system’ to accel-
erate cost-effective generation of new evidence
directly from and applicable to patient care
processes.5 6 This new model envisions conducting
clinical research as a byproduct of patient care.7
The increasing adoption of electronic health records
(EHRs) offers the exciting opportunity to permit
rich data collection and longitudinal analysis of
patients8 and to increase coordination between
patient care and patient-oriented research activities,
while reducing the burden on physicians, patients,
and healthcare delivery. EHRs can be used to
automate prescreening and, in turn, can signifi-
cantly improve recruitment efficiency and reduce
costs by excluding up to 90% of ineligible patients
who do not merit further review.9 Yet, clinicians
still have the potential to play a key role in assisting
researchers with recruitment. For example, one
study demonstrated that discussing potentially
eligible patients identified via EHR searches with
treating clinicians excluded an additional 60% of
potentially eligible patients for reasons not readily
identifiable by EHR scanning, such as alcohol
abuse, terminal illness, medication non-compliance,
or limited mobility.10 Therefore, a potentially cost-
effective approach that would facilitate collabora-
tion between clinicians and clinical researchers
would make use of EHRs to (1) automatically
prescreen patients to identify those who are
potentially eligible for research studies,9 10 (2)
prompt clinicians about research opportunities for
potentially eligible patients at the point of care,11
(3) facilitate contact between researchers and
clinicians to gather additional eligibility informa-
tion, (4) monitor scheduled clinic visits for eligible
patients, (5) automatically send information on
eligibility and visit schedules to study coordinators,
who could then approach potentially eligible
patients in connection with clinical visits for final
screening and possible consent,10 and (6) allow co-
scheduling of subsequent clinical and research visits
for study participants to minimize unnecessarily
redundant test orders.
Helpful as they can be, EHRs alone cannot
transform the clinical research enterprise. Table 1
lists major barriers to achieving the above vision,
our recommendations for needed changes, and the
identity of specific stakeholder groups that can act
to overcome the barriers. The first important
barrier is acquisition of clinical data directly from
clinicians.12 Information incompleteness and other
data quality issues are typical complaints about
EHR data for research. As a result of differences in
priorities between patient care and clinical research
settings, clinical data are not recorded with the
same care as research data.13 It is also believed that
EHRs have led not to improvements in the quality
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of the data being recorded, but rather to the recording of
a greater quantity of bad data.14 The imprecision of ICD-9
coding of medical problems and incompleteness in problem lists
can cause errors in electronic prescreening of patients.15 More
structured data entry based on clinical data standards may
improve data quality but can slow down clinicians.16 As
McDonald pointed out, ‘we have not quite figured out how to
capture the data from the physician in a structured and
computer-understandable form.’16
To solve this multifaceted problem, we need to closely engage
both informaticians and clinicians. Informaticians who design
EHRs could improve the accuracy and completeness of problem
lists and facilitate their use for research by providing a better
documentation interface with built-in consistency and
completeness validation. Structured narrative17 should be
explored as a potential solution that improves data documen-
tation quality while maintaining flexibility for clinicians. Clini-
cians also need to be incentivized to keep up-to-date, accurate
problem lists in some standardized fashion and be mindful of
how their recording practices can impact clinical research. The
current separation of payment systems between healthcare and
research needs reform. Policies for compensating clinicians for
supporting research need to be defined. Such policies may vary
between academic medical centers and community-based prac-
tices. The clinical research and patient care processes can hardly
be integrated if there is not a clear understanding of roles and
compensation for work.
Another major barrier stems from local policies intended to
comply with federal regulations to protect patient privacy. In
May 2002, the HHS Office of Inspector General issued a report
entitled, ‘Clinical Trial Websites: A Promising Tool to Foster
Informed Consent.’18 The Office of Inspector General report
recommended institutional review board (IRB) review of any
prescreening used for specific trials, which therefore becomes an
approach adopted by many IRBs. Indeed, in many institutions,
as exemplified by the guidelines for research recruitment at the
Johns Hopkins University,19 the patient recruitment plan must
be approved by the local IRB and researchers are required to
obtain a waiver, The Application for IRB Waiver of HIPAA
Privacy Authorization,19 for using protected health information
for prescreening. Even though scanning EHRs can efficiently
identify potential research participants, IRBs may reject such
requests from researchers out of concern that such practices
violate the federal health information privacy regulations
promulgated under the Health Insurance Portability and
Accountability Act (HIPAA).
Without explicit patient authorization, HIPAA regulations
generally limit access to medical records in entities covered by
the rules, that is, most health providers, health plans, and
healthcare clearinghouses, to persons directly involved in treat-
ment, billing, or healthcare operations. However, as noted by the
Institute of Medicine committee charged with examining the
effects of HIPAA on clinical research, many of the obstacles
result from overly conservative interpretation of the HIPAA
regulations or the federal regulations on protection of human
subjects by local IRBs.20 For example, according to the HIPAA
regulations, researchers who are members of the covered entity’s
workforce can conduct activities preparatory to research
involving access to patient data without patient authorization
or a formal waiver (45 CFR 164.512(i)(1)(ii)). Contrary to the
determinations of some IRBs, this regulation allows these
researchers to use protected health information in the EHR to
Table 1 Recommendations to optimize electronic health records (EHRs) for research
Barriers Recommendations Actions needed from
Inaccurate diagnostic codes and problem lists can
cause errors in electronic prescreening of patients
Improve the accuracy of problem lists in EHRs Informaticians*




Independent payment systems for patient care and
clinical research
Incentivize and compensate clinicians for their
support for clinical research, especially during
recruitment and research data collection
Administrators
Policy makers
Institutional privacy rules can limit use of EHRs to prescreen
patients for research




Ensure that the implementation of patient privacy
protection rules by local IRBs does not impede research
Policymakers (DHHS)
Enable appropriate information sharing and awareness
support between care and research teams
Informaticians
Policymakers (DHHS)
Overly conservative interpretation of the ‘common rule’
regulations to require primary care providers to give
permission to approach patients identified through EHR
screening potentially negates some of the benefits of EHR
screening
Limit requirements for PCP approval to higher-risk
clinical research protocols and clarify rules for selecting
appropriate care providers who can give permission to
researchers for prescreening and patient contact
Administrators
Local IRBs
Difficulty may exist in identifying primary clinicians caring
for patients in EHRs, which is important for communication
between researchers and clinicians
Improve the completeness of documentation and ability
to retrieve the identity of clinical care teams in EHRs
Informaticians
Clinicians
Failure to maximize potential for collaborative scheduling
between clinical and research visits can occur as a result
of privacy issues or lack of harmony between research and
clinical uses of EHRs
Grant ongoing access to clinical visit schedules by
researchers for coordinating clinical and research visits
Policymakers (DHHS)
Administrators
Enhance EHRs to coordinate clinical and research visits
for research participants
Informaticians
Mechanisms are lacking to add data on clinically relevant
research interventions (eg, study medications or therapies)
or test results to research participants’ EHRs, which can
adversely affect clinical care
Create ‘meaningful use of EHR’ rules that maximize
safety for research participants
Policymakers (ONC)
Provide informatics innovations to allow authorized,
specific information update in the EHR by researchers
Informaticians
Provide medication reconciliation for research patients
using data from both patient care and clinical research
Informaticians
Policymakers (DHHS)
*Informaticians are professionals who practice informatics, including biomedical informatics researchers and EHR vendors.
DHHS, Department of Health and Human Services; EHR, electronic health record; IRB, institutional review board; ONC, Office of National Coordinator (the originator of the meaningful use rules
for EHRs); PCP, primary care provider.
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identify and contact prospective research subjects even without
a formal waiver,21 although IRB approval may be desirable and
in some places will be required by institutional policy or state
law.21 22 Although patients generally want to control access to
their records for research purposes,23 we know of no data
documenting patients’ views on access simply to identify their
eligibility for research, which may be quite a different matter.
Clinical administrators and IRBs need to use the flexibility
already built into existing regulations to facilitate the research
process.
Another barrier that impedes EHRs from making recruitment
more efficient is the refusal by some IRBs to allow researchers to
approach patients identified by automated EHR prescreening
without obtaining permission from patients’ primary care
providers (PCPs).24 Although not mandated under the federal
research regulations (the ‘common rule’), the requirement of first
obtaining PCP consent before approaching patients is thought to
protect patients’ well-being and privacy,24 but can be problem-
atic for several reasons. First, allowing PCPs to decide for
a patient whether even to consider research participation may
violate patient autonomy,25 and requiring PCPs to introduce the
study may lead patients to feel unduly pressured to partici-
pate.26 In addition, it is often difficult to ascertain the identity of
patients’ PCPs27; some commercial EHRs fail to record the
members of the care team.28 Currently, many complex multi-
specialty provider networks have no formal policies for identi-
fying which clinicians can authorize researchers to contact
potentially eligible patients. Even when appropriate PCPs can be
identified, they may shy away from allowing their patients to be
approached out of concern that they lack both the knowledge to
respond to patients’ questions about the studies and the time for
such discussions. Nor is it practical to expect busy clinicians to
familiarize themselves with the details of research protocols;
thus, even when PCPs grant permission for patients to be
approached, it may not reflect informed judgments by the PCPs.
Although clearance by PCPs may make sense for some higher-
risk studiesdand an argument can be made that the increased
ease of screening EHRs to identify potential subjects could lead
to multiple requests of a particular patient, calling for someone
to play a gatekeeper roledroutine reliance on PCP agreement
is neither sensible nor efficient. Policymakers should
limit requirements for PCP approval to higher-risk clinical
research protocols and clarify rules for selecting appropriate
care providers who can give permission to researchers for
prescreening and patient contact.
For collaborative scheduling of clinical and research visits,
a significant barrier is that researchers often have difficulty
accessing patients’ clinical visit schedules. Researchers not
directly involved in a patient’s care may be precluded by HIPAA
from ongoing access to scheduling information without specific
patient authorization. Even with patient authorization, when
research staff external to the covered entity need access to
patient information, they may not be able to obtain it. A similar
unsolved problem involves medication reconciliation for research
participants. Often, researchers are not permitted to enter data
into EHRs and therefore are unable to indicate that the patient is
enrolled in a clinical trial or to note study medications and
research laboratory results. Absence of such information could
lead to adverse outcomes when uninformed care providers
prescribe drugs that interact with research drugs. Although
informaticians could create more sophisticated, research-friendly
access models, and provide secure mechanisms to allow infor-
mation sharing between researchers and clinicians, policymakers
at the US Department of Health and Human Services (who
oversee both HIPAA and human subject protection regulations)
need to create appropriate privacy policies that reduce barriers
for researchers. The collection of data to document the
frequency and severity of the ways in which current regulatory
approaches inhibit research will be essential to stimulate such
changes.29
Integration of clinical research activities with the process of
patient care would benefit patients, clinicians, and researchers,
but cannot be achieved by increased use of EHRs alone. Policy-
makers, administrators, IRBs, and informaticians all have
important roles to play. For example, regulatory changes are
needed to reconcile the implementation of HIPAA regulations
with federal regulations for human subject protection and to
maximize the value of EHR data for research, for example, by
clarifying and harmonizing rules governing activities prepara-
tory to research, which may include access to EHR data.20
Achieving this integration will likely require interdisciplinary
collaboration among ethics researchers, informatics experts,
clinicians, clinical researchers, and policy makers. Protecting the
safety and privacy of research participants while utilizing
technological advances to promote clinical research will require
everyone involved to accommodate appropriate protections for
research participants while capitalizing on EHRs’ potential to
facilitate research.
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